Scott is a molecular biologist specializing in molecular diagnostic testing, now acting as an executive within the In-Vitro Diagnostic Industry. Scott currently serves on the Boards of SafeWhite and Elimark. He was a certified clinical laboratory specialist in molecular biology, and a contributing author in the Journal of Molecular Diagnostics and The Journal of American Medical Association (JAMA).
Scott currently serves on the Board of SafeWhite and Elimark. He is a graduate of The Ohio State University in Molecular Genetics and holds an MBA from the University of Phoenix. He enjoys team sports, and actively brings his competitiveness to his biotechnology-based focuses.